Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma exports up 12.43 per cent during Apr-Dec 2021
India's exports of pharmaceutical products during April-December 2020-21 grew by 12.43 per cent to USD 17.57 billion, Parliament…
Pfizer drops India vaccine application after regulator seeks local trial
Pfizer said on Friday that it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after…
COVID-19 patients have higher risk of dying after cardiac arrest: Study
European Resuscitation Council and the Swedish Resuscitation Council issued guidelines recommending that bystanders who see a…
Natco Pharma gets registration approval from CIB&RC for Chlorantraniliprole
Natco Pharma has received registration approval from Central Insecticide Board and Registration Committee for Chlorantraniliprole,…
J&J files COVID-19 vaccine application with US FDA
Johnson & Johnson has asked US health regulators to authorise its single-dose COVID-19 vaccine for emergency use, and it will…
Pakistan says China’s Sinopharm vaccine not effective for people over 60 years
Pakistan on Thursday said that China's Sinopharm vaccine is not effective for people over 60 years of age, a day after it began…
Strides Pharma Q3 net profit declines 62 per cent to Rs 35 cr
Strides Pharma Science has reported a 61.93 per cent decline in consolidated net profit to Rs 35.15 crore for the quarter ended…
COVID-19 has accelerated innovation and experimentation in therapy development and clinical trials
Sunil Punjabi, Country Speaker & Head of Research Solutions Commercial, Merck India outlines how the COVID-19 pandemic is…
FDI India opening new avenues of foreign credit for India’s pharma sector
With access to large consumer markets, generation of new employment opportunities, increase in research and development and rise…
Malaysia sets February 2022 target to complete COVID-19 vaccine rollout
the government said the first batch of the vaccine jointly developed by US drugmaker Pfizer and German partner BioNTech is on…